Cybin Inc. - Common Stock (HELP)

6.7600
+0.6700 (11.00%)
NASDAQ · Last Trade: Feb 18th, 2:45 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
HELP Stock Rallies After Experimental Depression Drug Reduces Symptoms In Study: Retail Thinks Its ‘Time To Buy More’stocktwits.com
The study showed statistically significant and clinically meaningful reductions in depressive symptoms at two weeks in participants treated with SPL026 compared with placebo, the company said.
Via Stocktwits · February 17, 2026